Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2022

November 2017 | 104 pages | ID: G7AFB8415FEEN
QYResearch

Abstracts

This report studies the global Ophthalmic Therapeutics/Drug market, analyzes and researches the Ophthalmic Therapeutics/Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Novartis AG
• Allergan
• Santen Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Merck & Co., Inc.
• Genentech, Inc.
• Bayer AG
• Valeant
• Regeneron Pharmaceuticals Inc.
• Bausch & Lomb Incorporated
• Alcon
• Johnson and Johnson Vision Care, Inc.

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Antiallergy
• Anti-VEGF agents
• Anti-inflammatory
• Antiglaucoma
• Others

Market segment by Application, Ophthalmic Therapeutics/Drug can be split into

• Dry Eye
• Allergies
• Glaucoma
• Inflammation/Infection
• Retinal Disorders
• Uveitis
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF OPHTHALMIC THERAPEUTICS/DRUG

1.1 Ophthalmic Therapeutics/Drug Market Overview
  1.1.1 Ophthalmic Therapeutics/Drug Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Ophthalmic Therapeutics/Drug Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Ophthalmic Therapeutics/Drug Market by Type
  1.3.1 Antiallergy
  1.3.2 Anti-VEGF agents
  1.3.3 Anti-inflammatory
  1.3.4 Antiglaucoma
  1.3.5 Others
1.4 Ophthalmic Therapeutics/Drug Market by End Users/Application
  1.4.1 Dry Eye
  1.4.2 Allergies
  1.4.3 Glaucoma
  1.4.4 Inflammation/Infection
  1.4.5 Retinal Disorders
  1.4.6 Uveitis
  1.4.7 Others

2 GLOBAL OPHTHALMIC THERAPEUTICS/DRUG COMPETITION ANALYSIS BY PLAYERS

2.1 Ophthalmic Therapeutics/Drug Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Novartis AG
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Allergan
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Santen Pharmaceutical Co., Ltd.
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Pfizer Inc.
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Merck & Co., Inc.
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Genentech, Inc.
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Bayer AG
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Valeant
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Regeneron Pharmaceuticals Inc.
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Bausch & Lomb Incorporated
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Ophthalmic Therapeutics/Drug Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Alcon
3.12 Johnson and Johnson Vision Care, Inc.

4 GLOBAL OPHTHALMIC THERAPEUTICS/DRUG MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Ophthalmic Therapeutics/Drug Market Size by Type (2012-2017)
4.2 Global Ophthalmic Therapeutics/Drug Market Size by Application (2012-2017)
4.3 Potential Application of Ophthalmic Therapeutics/Drug in Future
4.4 Top Consumer/End Users of Ophthalmic Therapeutics/Drug

5 UNITED STATES OPHTHALMIC THERAPEUTICS/DRUG DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Ophthalmic Therapeutics/Drug Market Size (2012-2017)
5.2 United States Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

6 EU OPHTHALMIC THERAPEUTICS/DRUG DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Ophthalmic Therapeutics/Drug Market Size (2012-2017)
6.2 EU Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

7 JAPAN OPHTHALMIC THERAPEUTICS/DRUG DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Ophthalmic Therapeutics/Drug Market Size (2012-2017)
7.2 Japan Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

8 CHINA OPHTHALMIC THERAPEUTICS/DRUG DEVELOPMENT STATUS AND OUTLOOK

8.1 China Ophthalmic Therapeutics/Drug Market Size (2012-2017)
8.2 China Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

9 INDIA OPHTHALMIC THERAPEUTICS/DRUG DEVELOPMENT STATUS AND OUTLOOK

9.1 India Ophthalmic Therapeutics/Drug Market Size (2012-2017)
9.2 India Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA OPHTHALMIC THERAPEUTICS/DRUG DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Ophthalmic Therapeutics/Drug Market Size (2012-2017)
10.2 Southeast Asia Ophthalmic Therapeutics/Drug Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Ophthalmic Therapeutics/Drug Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
  11.1.2 EU Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
  11.1.4 China Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
  11.1.5 India Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Ophthalmic Therapeutics/Drug Revenue and Growth Rate (2017-2022)
11.2 Global Ophthalmic Therapeutics/Drug Market Size (Value) by Type (2017-2022)
11.3 Global Ophthalmic Therapeutics/Drug Market Size by Application (2017-2022)

12 OPHTHALMIC THERAPEUTICS/DRUG MARKET DYNAMICS

12.1 Ophthalmic Therapeutics/Drug Market Opportunities
12.2 Ophthalmic Therapeutics/Drug Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Ophthalmic Therapeutics/Drug Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Ophthalmic Therapeutics/Drug Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Ophthalmic Therapeutics/Drug Product Scope
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) (2012-2017)
Table Global Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Ophthalmic Therapeutics/Drug Market Share by Regions in 2016
Figure United States Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Ophthalmic Therapeutics/Drug Market Share by Type in 2016
Figure Antiallergy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Anti-VEGF agents Market Size (Million USD) and Growth Rate (2012-2017)
Figure Anti-inflammatory Market Size (Million USD) and Growth Rate (2012-2017)
Figure Antiglaucoma Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Ophthalmic Therapeutics/Drug Market Share by Application in 2016
Table Key Downstream Customer in Dry Eye
Figure Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate in Dry Eye (2012-2017)
Table Key Downstream Customer in Allergies
Figure Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate in Allergies (2012-2017)
Table Key Downstream Customer in Glaucoma
Figure Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate in Glaucoma (2012-2017)
Table Key Downstream Customer in Inflammation/Infection
Figure Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate in Inflammation/Infection (2012-2017)
Table Key Downstream Customer in Retinal Disorders
Figure Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate in Retinal Disorders (2012-2017)
Table Key Downstream Customer in Uveitis
Figure Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate in Uveitis (2012-2017)
Table Key Downstream Customer in Others
Figure Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Ophthalmic Therapeutics/Drug Market Size (Million USD) by Players (2016 and 2017)
Figure Ophthalmic Therapeutics/Drug Market Size Share by Players in 2016
Figure Ophthalmic Therapeutics/Drug Market Size Share by Players in 2017
Table Novartis AG Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Novartis AG (2012-2017)
Figure Novartis AG Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Allergan Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Allergan (2012-2017)
Figure Allergan Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Santen Pharmaceutical Co., Ltd. Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Santen Pharmaceutical Co., Ltd. (2012-2017)
Figure Santen Pharmaceutical Co., Ltd. Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Pfizer Inc. Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Pfizer Inc. (2012-2017)
Figure Pfizer Inc. Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Merck & Co., Inc. Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Merck & Co., Inc. (2012-2017)
Figure Merck & Co., Inc. Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Genentech, Inc. Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Genentech, Inc. (2012-2017)
Figure Genentech, Inc. Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Bayer AG Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Bayer AG (2012-2017)
Figure Bayer AG Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Valeant Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Valeant (2012-2017)
Figure Valeant Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Regeneron Pharmaceuticals Inc. Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Regeneron Pharmaceuticals Inc. (2012-2017)
Figure Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Bausch & Lomb Incorporated Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Bausch & Lomb Incorporated (2012-2017)
Figure Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Alcon Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Alcon (2012-2017)
Figure Alcon Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Johnson and Johnson Vision Care, Inc. Basic Information List
Table Ophthalmic Therapeutics/Drug Business Revenue (Million USD) of Johnson and Johnson Vision Care, Inc. (2012-2017)
Figure Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Business Revenue Market Share in 2016
Table Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Type (2012-2017)
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Type in 2012
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Type in 2013
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Type in 2014
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Type in 2015
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Type in 2016
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Type in 2017
Table Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application (2012-2017)
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application in 2012
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application in 2013
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application in 2014
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application in 2015
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application in 2016
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Ophthalmic Therapeutics/Drug
Figure United States Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Ophthalmic Therapeutics/Drug Market Size (Million USD) by Players (2012-2017)
Figure United States Ophthalmic Therapeutics/Drug Market Size Share by Players in 2016
Figure United States Ophthalmic Therapeutics/Drug Market Size Share by Players in 2017
Figure EU Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Ophthalmic Therapeutics/Drug Market Size (Million USD) by Players (2012-2017)
Figure EU Ophthalmic Therapeutics/Drug Market Size Share by Players in 2016
Figure EU Ophthalmic Therapeutics/Drug Market Size Share by Players in 2017
Figure Japan Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Ophthalmic Therapeutics/Drug Market Size (Million USD) by Players (2012-2017)
Figure Japan Ophthalmic Therapeutics/Drug Market Size Share by Players in 2016
Figure Japan Ophthalmic Therapeutics/Drug Market Size Share by Players in 2017
Figure China Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Ophthalmic Therapeutics/Drug Market Size (Million USD) by Players (2012-2017)
Figure China Ophthalmic Therapeutics/Drug Market Size Share by Players in 2016
Figure China Ophthalmic Therapeutics/Drug Market Size Share by Players in 2017
Figure India Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Ophthalmic Therapeutics/Drug Market Size (Million USD) by Players (2012-2017)
Figure India Ophthalmic Therapeutics/Drug Market Size Share by Players in 2016
Figure India Ophthalmic Therapeutics/Drug Market Size Share by Players in 2017
Figure Southeast Asia Ophthalmic Therapeutics/Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Ophthalmic Therapeutics/Drug Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Ophthalmic Therapeutics/Drug Market Size Share by Players in 2016
Figure Southeast Asia Ophthalmic Therapeutics/Drug Market Size Share by Players in 2017
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Regions (2017-2022)
Table Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Regions (2017-2022)
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Regions in 2017
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Regions in 2022
Figure United States Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Ophthalmic Therapeutics/Drug Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Type (2017-2022)
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Type in 2017
Figure Global Ophthalmic Therapeutics/Drug Market Size Share by Type in 2022
Table Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application (2017-2022)
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application in 2017
Figure Global Ophthalmic Therapeutics/Drug Market Size (Million USD) by Application in 2022